ESR1 and breast carcinoma: Our study expands on this study, further evaluating the association between ER/PR status and breast cancer-specific mortality within subgroups of women defined by personal characteristics (including race/ethnicity, age at cancer diagnosis, and year of cancer diagnosis) and tumor characteristics (including histology, stage, grade, size, and axillary lymph node metastases).